BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 23909000)

  • 1. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; MacMaster SA; Seiters J
    J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Mueser KT; Drake RE
    Drug Alcohol Rev; 2004 Dec; 23(4):471-81. PubMed ID: 15763752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between older and younger adults in residential treatment for co-occurring disorders.
    Morse SA; Watson C; MacMaster SA; Bride BE
    J Dual Diagn; 2015; 11(1):75-82. PubMed ID: 25531670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
    Moos RH; Moos BS
    Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.
    Broome KM; Flynn PM; Simpson DD
    Health Serv Res; 1999 Aug; 34(3):791-806. PubMed ID: 10445903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spirituality, sense of coherence, and coping responses in women receiving treatment for alcohol and drug addiction.
    Arévalo S; Prado G; Amaro H
    Eval Program Plann; 2008 Feb; 31(1):113-23. PubMed ID: 17825910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship Between Residential Mobility and Behavioral Health Service Use in a National Sample of Adults With Mental Health and/or Substance Abuse Problems.
    Yuan Y; Manuel JI
    J Dual Diagn; 2018; 14(4):201-210. PubMed ID: 30303466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of residential treatment of substance abuse in hospital- and community-based programs.
    Moos RH; King MJ; Patterson MA
    Psychiatr Serv; 1996 Jan; 47(1):68-74. PubMed ID: 8925349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of co-occurring disorders and intimate partner violence on substance abuse treatment outcomes.
    Lipsky S; Krupski A; Roy-Byrne P; Lucenko B; Mancuso D; Huber A
    J Subst Abuse Treat; 2010 Apr; 38(3):231-44. PubMed ID: 20129753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of opiate users leaving detoxification treatment against medical advice.
    Kenne DR; Boros AP; Fischbein RL
    J Addict Dis; 2010 Jul; 29(3):383-94. PubMed ID: 20635287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of a sleep hygiene intervention on residents of a private residential facility for individuals with co-occurring mental health and substance use disorders: results of a pilot study.
    Morse SA; MacMaster SA; Kodad V; Robledo K
    J Addict Nurs; 2014; 25(4):204-8. PubMed ID: 25514691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health and medical problems and service use among adolescent substance users.
    Jaycox LH; Morral AR; Juvonen J
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):701-9. PubMed ID: 12921478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief screening for co-occurring disorders among women entering substance abuse treatment.
    Lincoln AK; Liebschutz JM; Chernoff M; Nguyen D; Amaro H
    Subst Abuse Treat Prev Policy; 2006 Sep; 1():26. PubMed ID: 16959041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engaging substance abusers after centralized assessment: predictors of treatment entry and dropout.
    Claus RE; Kindleberger LR
    J Psychoactive Drugs; 2002; 34(1):25-31. PubMed ID: 12003110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders.
    DiClemente CC; Nidecker M; Bellack AS
    J Subst Abuse Treat; 2008 Jan; 34(1):25-35. PubMed ID: 17574798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment process in the therapeutic community: associations with retention and outcomes among adolescent residential clients.
    Edelen MO; Tucker JS; Wenzel SL; Paddock SM; Ebener P; Dahl J; Mandell W
    J Subst Abuse Treat; 2007 Jun; 32(4):415-21. PubMed ID: 17481465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.